Effects of sodium butyrate on oxidative stress and behavioral changes induced by administration of d-AMPH

Neurochemistry International

Volumn 62, Issue 4, 2013, Pages 425-432

  Steckert, Amanda V ^a   Valvassori, Samira S ^a   Varela, Roger B ^a   Mina, Francielle ^a   Resende, Wilson R ^a   Bavaresco, Daniela V ^a   Ornell, Felipe ^a   Dal Pizzol, Felipe ^a   Quevedo, João ^a  

^a UNIVERSITY OF SOUTHERN SANTA CATARINA   (Brazil)

Author keywords

Bipolar disorder; d Amphetamine; Histone deacetylase; Mania; Oxidative stress; Sodium butyrate

Indexed keywords

BUTYRIC ACID; CARBONYL PROTEIN; CATALASE; DEXAMPHETAMINE; PROTEIN; UNCLASSIFIED DRUG;

AMYGDALOID NUCLEUS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BEHAVIOR CHANGE; BIPOLAR DISORDER; CONTROLLED STUDY; CORPUS STRIATUM; ENZYME ACTIVITY; HIPPOCAMPUS; LOCOMOTION; MALE; MANIA; MOTOR ACTIVITY; NONHUMAN; OPEN FIELD TEST; OXIDATIVE STRESS; PREFRONTAL CORTEX; PRIORITY JOURNAL; RAT;

ANIMALS; BEHAVIOR, ANIMAL; BUTYRATES; DEXTROAMPHETAMINE; MALE; OXIDATIVE STRESS; RATS; RATS, WISTAR;

EID: 84875130684     PISSN: 01970186     EISSN: 18729754     Source Type: Journal    
DOI: 10.1016/j.neuint.2013.02.001     Document Type: Article

References (64)

1. H. Aebi Catalase in vitro Methods Enzymol. 105 1984 121 126
2. A. Agmo, R.G. Paredes, J.I. Ramos, and J.L. Contreras Dopamine and sexual behavior in the male rabbit Pharmacol. Biochem. Behav. 55 2 1996 289 295
3. A. Anand, P. Verhoeff, N. Seneca, S.S. Zoghbi, J.P. Seibyl, D.S. Charney, and R.B. Innis Brain SPECT imaging of amphetamine-induced dopamine release in euthymic bipolar disorderpatients Am. J. Psychiatry 157 7 2000 1108 1114
4. A.C. Andreazza, C. Cassini, A.R. Rosa, M.C. Leite, L.M. de Almeida, P. Nardin, A.B. Cunha, K.M. Cereser, A. Santin, C. Gottfried, M. Salvador, F. Kapczinski, and C.A. Gonçalves Serum S100B and antioxidant enzymes in bipolar patients J. Psychiatr. Res. 41 2007 523 529
5. A.C. Andreazza, M. Kauer-Sant'anna, B.N. Frey, D.J. Bond, F. Kapczinski, L.T. Young, and L.N. Yatham Oxidative stress markers in bipolar disorder: a meta-analysis J. Affect Disord. 111 2008 135 144
6. J.V. Bannister, and L. Calabrese Assays for superoxide dismutase Methods Biochem. Anal. 32 1987 279 312
7. L.M. Butler, X. Zhou, W.S. Xu, H.I. Scher, R.A. Rifkind, P.A. Marks, and V.A. Richon The histone deacetylase inhibitor SAHA arrests cancer cell growth, up-regulates thioredoxinbinding protein-2, and down-regulates thioredoxin Proc. Natl. Acad. Sci. USA 99 2002 11700 11705
8. P. Cappeliez, and E. Moore Effects of lithium on an amphetamine animal model of bipolar disorder Prog. Neuropsychopharmacol. Biol. Psychiatry. 14 3 1990 347 358
9. P.S. Chen, G.S. Peng, G. Li, S. Yang, X. Wu, C.C. Wang, B. Wilson, R.B. Lu, P.W. Gean, D.M. Chuang, and J.S. Hong Valproate protects dopaminergic neurons in midbrain neuron/glia cultures by stimulating the release of neurotrophic factors from astrocytes Mol. Psychiatry 11 12 2006 1116 1125
10. J. Cott, and J. Engel Antagonism of the analeptic activity of thyrotropin-releasing hormone (TRH) by agents which enhance GABA transmission Psychopharmacology (Berlin) 52 2 1977 145 149
11. H. Dou, K. Birusingh, J. Faraci, S. Gorantla, L.Y. Poluektova, S.B. Maggirwar, S. Dewhurst, H.A. Gelbard, and H.E. Gendelman Neuroprotective activities of sodium valproate in a murine model of human immunodeficiency virus-1 encephalitis J. Neurosci. 23 27 2003 9162 9170
12. H.H. Draper, and M. Hadley Malondialdehyde determination as index of lipid peroxidation Methods Enzymol. 186 1990 421 431
13. H. Einat, P. Yuan, T.D. Gould, J. Li, J. Du, L. Zhang, H.K. Manji, and G. Chen The role of the extracellular signal-regulated kinase signaling pathway in mood modulation J. Neurosci. 23 2003 7311 7316
14. H. Einat, P. Yuan, S.T. Szabo, S. Dogra, and H.K. Manji Protein kinase C inhibition by tamoxifen antagonizes manic-like behavior in rats: implications for the development of novel therapeutics for bipolar disorder Neuropsychobiology 55 3-4 2007 123 131
15. A.E. Evins, C. Demopulos, A. Nierenberg, M.A. Culhane, L. Eisner, and G. Sachs A double-blind, placebo-controlled trial of adjunctive donepezil in treatment-resistant mania Bipolar Disord. 8 2006 75 80
16. B.S. Fernandes, C.S. Gama, K.M. Ceresér, L.N. Yatham, G.R. Fries, G. Colpo, D. de Lucena, M. Kunz, F.A. Gomes, and F. Kapczinski Brain-derived neurotrophic factor as a state-marker of mood episodes in bipolar disorders: a systematic review and meta-regression analysis J. Psychiatr. Res. 45 2011 995 1004
17. D.F. Fiorino, and A.G. Phillips Facilitation of sexual behavior and enhanced dopamine efflux in the nucleus accumbens of male rats after d-amphetamine-induced behavioral sensitization J. Neurosci. 19 1 1999 456 463
18. B.N. Frey, S.S. Valvassori, G.Z. Réus, M.R. Martins, F.C. Petronilho, K. Bardini, F. Dal-Pizzol, F. Kapczinski, and J. Quevedo Effects of lithium and valproate on amphetamine-induced oxidative stress generation in an animal model of mania Neurochem. Res. 31 5 2006 326 332
19. B.N. Frey, S.S. Valvassori, G.Z. Réus, M.R. Martins, F.C. Petronilho, K. Bardini, F. Dal-Pizzol, F. Kapczinski, and J. Quevedo Changes in antioxidant defense enzymes after d-amphetamine exposure: implications as an animal model of mania Neurochem. Res. 31 5 2006 699 703
20. B.N. Frey, S.S. Valvassori, K.M. Gomes, M.R. Martins, F. Dal-Pizzol, F. Kapczinski, and J. Quevedo Increased oxidative stress in submitochondrial particles after chronic amphetamine exposure Brain Res. 1097 1 2006 224 229
21. T. Fukumoto, S. Morinobu, Y. Okamoto, A. Kagaya, and S. Yamawaki Chronic lithium treatment increases the expression of brain-derived neurotrophic factor in the rat brain Psychopharmacology 158 2001 100 106
22. H.S. Gergerlioglu, H.A. Savas, F. Bulbul, S. Selek, E. Uz, and M. Yumru Changes in nitric oxide level and superoxide dismutase activity during antimanic treatment Prog. Neuropsychopharmacol. Biol. Psychiatry 31 2007 697 702
23. Goodwin, F.K.; Jamison, K.R. 1990. Manic Depressive Illness, ed 1. New York, Oxford University. Hahn, C.G.; Friedman, E. Abnormalities in protein kinase C signaling and the pathophysiology of bipolar disorder. Bipolar Disord. 1, 81-86.
24. M. Göttlicher, S. Minucci, P. Zhu, O.H. Krämer, A. Schimpf, S. Giavara, J.P. Sleeman, F. Lo Coco, C. Nervi, P.G. Pelicci, and T. Heinzel Valproic acid defines a novel class of HDAC inhibitors inducing differentiation of transformed cells EMBO J. 20 24 2001 6969 6978
25. N.B. Gross, P.C. Duncker, and J.F. Marshall Cortical ionotropic glutamate receptor antagonism protects against methamphetamine-induced striatal neurotoxicity Neuroscience 199 2011 272 283
26. B.B. Gundersen, and J.A. Blendy Effects of the histone deacetylase inhibitor sodium butyrate in models of depression and anxiety Neuropharmacology 57 1 2009 67 74
27. L.K. Jornada, S.S. Valvassori, A.V. Steckert, M. Moretti, F. Mina, C.L. Ferreira, C.O. Arent, F. Dal-Pizzol, and J. Quevedo Lithium and valproate modulate antioxidant enzymes and prevent ouabain-induced oxidative damage in an animal model of mania J. Psychiatr. Res. 45 2011 162 168
28. L.K. Jornada, M. Moretti, S.S. Valvassori, C.L. Ferreira, P.T. Padilha, C.O. Arent, G.R. Fries, F. Kapczinski, and J. Quevedo Effects of mood stabilizers on hippocampus and amygdala BDNF levels in an animal model of mania induced by ouabain J. Psychiatr. Res. 44 2010 506 510
29. F. Kapczinski, B.N. Frey, A.C. Andreazza, M. Kauer-Sant'Anna, A.B. Cunha, and R.M. Post Increased oxidative stress as a mechanism for decreased BDNF levels in acute manic episodes Rev. Bras. Psiquiatr. 30 2008 243 245
30. P.E. Keck Jr. The management of acute mania BMJ 327 2003 1002 1003
31. T. Kouzarides Chromatin modifications and their function Cell 128 2007 693 706
32. A. Kumar, K.H. Choi, W. Renthal, N.M. Tsankova, D.E. Theobald, H.T. Truong, S.J. Russo, Q. Laplant, T.S. Sasaki, K.N. Whistler, R.L. Neve, D.W. Self, and E.J. Nestler Chromatin remodeling is a key mechanism underlying cocaine-induced plasticity in striatum Neuron 48 2005 303 314
33. B. Langley, M.A. D'Annibale, K. Suh, I. Ayoub, A. Tolhurst, B. Bastan, L. Yang, B. Ko, M. Fisher, S. Cho, M.F. Beal, and R.R. Ratan Pulse inhibition of histone deacetylases induces complete resistance to oxidative death in cortical neurons without toxicity and reveals a role for cytoplasmic p21(waf1/cip1) in cell cycle-independent neuroprotection J. Neurosci. 28 1 2008 163 176
34. Y. Leng, M.H. Liang, M. Ren, Z. Marinova, P. Leeds, and D.M. Chuang Synergistic neuroprotective effects of lithium and valproic acid or other histone deacetylase inhibitors in neurons: roles of glycogen synthase kinase-3 inhibition J. Neurosci. 28 10 2008 2576 2588
35. Y. Leng, and D.M. Chuang Endogenous alpha-synuclein is induced by valproic acid through histone deacetylase inhibition and participates in neuroprotection against glutamate-induced excitotoxicity J. Neurosci. 26 28 2006 7502 7512
36. R.L. Levine, J.A. Williams, E.R. Stadtman, and E. Shacter Carbonyl assays for determination of oxidatively modified proteins Methods Enzymol. 233 1994 346 357
37. P.Y. Lin State-dependent decrease in levels of brain-derived neurotrophic factor in bipolar disorder: a meta-analytic study Neurosci. Lett. 466 2009 139 143
38. O.H. Lowry, N.J. Rosebrough, A.L. Farr, and R.J. Randall Protein measurement with the Folin phenol reagent J. Biol. Chem. 193 1951 265 267
39. R. Machado-Vieira, A.C. Andreazza, C.I. Viale, V. Zanatto, V. Cereser Jr, R. da Silva-Vargas, F. Kapczinski, L.V. Portela, D.O. Souza, M. Salvador, and V. Gentil Oxidative stress parameters in unmedicated and treated bipolar subjects during initial manic episode: a possible role for lithium antioxidant effects Neurosci. Lett. 421 1 2007 33 36
40. M. Moretti, S.S. Valvassori, R.B. Varela, C.L. Ferreira, N. Rochi, J. Benedet, G. Scaini, F. Kapczinski, E.L. Streck, A.I. Zugno, and J. Quevedo Behavioral and neurochemical effects of sodium butyrate in an animal model of mania Behav. Pharmacol. 22 2011 766 772
41. A. Nishiyama, M. Matsui, S. Iwata, K. Hirota, H. Masutani, H. Nakamura, Y. Takagi, H. Sono, Y. Gon, and J. Yodoi Identification of thioredoxin-binding protein-2/vitamin D(3) up-regulated protein 1 as a negative regulator of thioredoxin function and expression J. Biol. Chem. 274 1999 21645 21650
42. M.J. Owens, and C.B. Nemeroff Pharmacology of valproate Psychopharmacol. Bull. 37 2 2003 17 24
43. H.F. Poon, V. Calabrese, G. Scapagnini, and D.A. Butterfield Free radicals and brain aging Clin. Geriatr. Med. 20 2004 329 359
44. C.J. Phiel, F. Zhang, E.Y. Huang, M.G. Guenther, M.A. Lazar, and P.S. Klein Histone deacetylase is a direct target of valproic acid, a potent anticonvulsant, mood stabilizer, and teratogen J. Biol. Chem. 276 2001 36734 36741
45. P.K. Ranjekar, A. Hinge, M.V. Hegde, M. Ghate, A. Kale, S. Sitasawad, U.V. Wagh, V.B. Debsikdar, and S.P. Mahadik Decreased antioxidant enzymes and membrane essential polyunsaturated fatty acids in schizophrenic and bipolar mood disorder patients Psychiatry Res. 121 2003 109 122
46. R. Reddy, S. Mukherjee, D.B. Schnur, J. Chin, and G. Degreef History of obstetric complications, family history, and CT scan findings in schizophrenic patients Schizophr. Res. 3 5-6 1990 311 314
47. R.R. Rosato, J.A. Almenara, Y. Daí, and S. Grant Simultaneous activation of the intrinsic and extrinsic pathways by histone deacetylase (HDAC) inhibitors and tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) synergistically induces mitochondrial damage and apoptosis in human leukemia cells Mol. Cancer Ther. 2 2003 1273 1284
48. H. Ryu, J. Lee, B.A. Olofsson, A. Mwidau, A. Dedeoglu, M. Escudero, E. Flemington, J. Azizhan-Clifford, R.J. Ferrante, and R.R. Ratan Histone deacetylase inhibitors prevent oxidative neuronal death independent of expanded polyglutamine repeats via an Spl-dependent pathway Proc. Natl. Acad. Sci. USA 100 2003 4281 4286
49. M.R. Sandoval, and J. Palermo-Neto Effect of manipulation of the GABA system on dopamine-related behaviors Braz. J. Med. Biol. Res. 28 1 1995 88 99
50. F.A. Schröeder, K.L. Penta, A. Matevossian, S.R. Jones, C. Konradi, A.R. Tapper, and S. Akbarian Drug-induced activation of dopamine D(1) receptor signaling and inhibition of class I/II histone deacetylase induce chromatin remodeling in reward circuitry and modulate cocaine-related behaviors Neuropsychopharmacology 33 12 2008 2981 2992
51. F.A. Schröeder, C.L. Lin, W.E. Crusio, and S. Akbarian Antidepressant-like effects of the histone deacetylase inhibitor, sodium butyrate, in the mouse Biol. Psychiatry 62 2007 55 64
52. A.V. Steckert, S.S. Valvassori, M. Moretti, F. Dal-Pizzol, and J. Quevedo Role of oxidative stress in the pathophysiology of bipolar disorder Neurochem. Res. 35 2010 1295 1301
53. S.M. Strakowski, and K.W. Sax Progressive behavioral response to repeated d-amphetamine challenge: further evidence for sensitization in humans Biol. Psychiatry 44 11 1998 1171 1177
54. S.T. Szabo, R. Machado-Vieira, P. Yuan, Y. Wang, Y. Wei, C. Falke, C. Cirelli, G. Tononi, H.K. Manji, and J. Du Glutamate receptors as targets of protein kinase C in the pathophysiology and treatment of animal models of mania Neuropharmacology 56 1 2009 47 55
55. J. Tramontina, B.N. Frey, A.C. Andreazza, M. Zandona, A. Santin, and F. Kapczinski Val66met polymorphism and serum brain-derived neurotrophic factor levels in bipolar disorder Mol. Psychiatry 12 2007 230 231
56. J.S. Ungerstedt, Y. Sowa, W.S. Xu, Y. Shao, M. Dokmanovic, G. Perez, L. Ngo, A. Holmgren, X. Jiang, and P.A. Marks Role of thioredoxin in the response of normal and transformed cells to histone deacetylase inhibitors Proc. Natl. Acad. Sci. USA 102 2005 673 678
57. S.S. Valvassori, M. Moretti, M. Kauer-Sant'Anna, R. Roesler, F. Petronilho, G. Schwartsmann, F. Kapczinski, F. Dal-Pizzol, and J. Quevedo Effects of a gastrin-releasing peptide receptor antagonist on d-amphetamine-induced oxidative stress in the rat brain J. Neural Transm. 117 3 2010 309 316
58. S.S. Valvassori, F.C. Petronilho, G.Z. Réus, A.V. Steckert, V.B. Oliveira, C.R. Boeck, F. Kapczinski, F. Dal-Pizzol, and J. Quevedo Effect of N-acetylcysteine and/or deferoxamine on oxidative stress and hyperactivity in an animal model of mania Prog. Neuropsychopharmacol. Biol. Psychiatry 32 4 2008 1064 1068
59. Z. Wang, Y. Leng, L.K. Tsai, P. Leeds, and D.M. Chuang Valproic acid attenuates blood-brain barrier disruption in a rat model of transient focal cerebral ischemia: the roles of HDAC and MMP-9 inhibition J. Cereb. Blood Flow Metab. 31 1 2011 52 57
60. J.Y. Wu, F.N. Niu, R. Huang, and Y. Xu Enhancement of glutamate uptake in 1-methyl-4-phenylpyridinium-treated astrocytes by trichostatin A Neuroreport 19 12 2008 1209 1212
61. X. Wu, P.S. Chen, S. Dallas, B. Wilson, M.L. Block, C.C. Wang, H. Kinyamu, N. Lu, X. Gao, Y. Leng, D.M. Chuang, W. Zhang, R.B. Lu, and J.S. Hong Histone deacetylase inhibitors up-regulate astrocyte GDNF and BDNF gene transcription and protect dopaminergic neurons Int. J. Neuropsychopharmacol. 11 2008 1123 1134
62. W.S. Xu, R.B. Parmigiani, and P.A. Marks Histone deacetylase inhibitors: molecular mechanisms of action Oncogene 26 2007 5541 5552
63. Y. Yamawaki, M. Fuchikami, S. Morinobu, M. Segawa, T. Matsumoto, and S. Yamawaki Antidepressant-like effect of sodium butyrate (HDAC inhibitor) and its molecular mechanism of action in the rat hippocampus World J. Biol. Psychiatry 13 6 2011 458 467
64. P. Young, B.C. Finn, F. Alvarez, J.E. Bruetman, and H. Trimarchi Valproate-associated hyperammonemic encephalopathy Rev. Med. Chil. 135 11 2007 1446 1449